Erbitux and Pancreatitis - a phase IV clinical study of FDA data

Summary:

Pancreatitis is reported as a side effect among people who take Erbitux (cetuximab), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Magnesium Sulfate, and have Oral cancer.

The phase IV clinical study analyzes which people have Pancreatitis when taking Erbitux. It is created by eHealthMe based on reports of 19,227 people who have side effects when taking Erbitux from the FDA, and is updated regularly.

What is Erbitux?

Erbitux has active ingredients of cetuximab. It is often used in cancer. eHealthMe is studying from 19,276 Erbitux users. Check the latest studies of Erbitux.

What is Pancreatitis?

Pancreatitis (inflammation of pancreas) is found to be associated with 1,765 drugs and 2,025 conditions by eHealthMe. Check the latest studies of Pancreatitis.

On Jul, 14, 2026

19,227 people reported to have side effects when taking Erbitux.
Among them, 25 people (0.13%) have Pancreatitis.

Among these 25 people:

How long have people been on Erbitux when they have Pancreatitis? *

What is the gender of people who have Pancreatitis when taking Erbitux? *

female: 32 %
male: 68 %

What is the age of people who have Pancreatitis when taking Erbitux? *

What are other drugs people take besides Erbitux? *

What are other side effects people have besides Pancreatitis? *

Abdominal Pain: 3 people, 12.00%
Pancreatitis Acute (sudden inflammation of pancreas): 3 people, 12.00%
Fatigue (feeling of tiredness): 2 people, 8.00%
Confusional State: 2 people, 8.00%
Dizziness: 2 people, 8.00%
Drowsiness: 2 people, 8.00%
Dyspnea (difficult or laboured breathing): 2 people, 8.00%
Renal Impairment (severely reduced kidney function): 2 people, 8.00%
Weight Decreased: 2 people, 8.00%
Hypotension (abnormally low blood pressure): 2 people, 8.00%

What are the existing conditions these people have? *

Oral Cancer (mouth cancer): 5 people, 20.00%
Colon Cancer: 4 people, 16.00%
Colon Cancer Metastatic (cancer of colon spreads to other part of body): 4 people, 16.00%
High Blood Pressure: 3 people, 12.00%
Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 3 people, 12.00%
Tongue Neoplasm Malignant Stage Unspecified: 2 people, 8.00%
Constipation: 2 people, 8.00%
Stress And Anxiety: 2 people, 8.00%
Endocarditis (inflammation in heart muscle): 2 people, 8.00%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Erbitux and have Pancreatitis?

- Check whether Pancreatitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Erbitux:

Erbitux (19,276 reports)

Pancreatitis treatments and more:

Pancreatitis (62,704 reports)

Browse all side effects of Erbitux:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pancreatitis:

Pancreatitis (1,765 drugs)

Browse all the conditions that are associated with Pancreatitis:

Pancreatitis (2,025 conditions)

Related publications that referenced our studies

Sirkeci, ?., Sirkeci, E. E., & Ta?el, B. , "Rivaroxaban-induced acute pancreatitis", The European Research Journal, 2018 Jan .
Liao, K. F., Huang, P. T., Lin, C. C., Lin, C. L., & Lai, S. W., "Fluvastatin use and risk of acute pancreatitis: a population-based case-control study in Taiwan", Biomedicine, 2014 Jan .
Arshad F, Ladakhi Y, Khan MA, "A rare case of carbamazepine induced pancreatitis", International Journal of Students’ Research, 2013 Jul .
Das S, Mondal S, Dey JK, Bandyopadhyay S, Saha I, Tripathi SK, "A case of montelukast induced hypercholesterolemia, severe hypertriglyceridemia and pancreatitis", Journal of Young Pharmacists, 2013 Jun .
Gupta D, Shukla P, Bisht SS, Bhatt ML, Pant MC, Srivastava K, "Deep vein and artery thrombosis associated with cetuximab-based chemoradiotherapy", Indian journal of pharmacology, 2011 Jan .
Sirkeci, ?., Sirkeci, E. E., & Ta?el, B. , "Rivaroxaban-induced acute pancreatitis", The European Research Journal, 2018 Jan .
Liao, K. F., Huang, P. T., Lin, C. C., Lin, C. L., & Lai, S. W., "Fluvastatin use and risk of acute pancreatitis: a population-based case-control study in Taiwan", Biomedicine, 2014 Jan .
Arshad F, Ladakhi Y, Khan MA, "A rare case of carbamazepine induced pancreatitis", International Journal of Students’ Research, 2013 Jul .
Das S, Mondal S, Dey JK, Bandyopadhyay S, Saha I, Tripathi SK, "A case of montelukast induced hypercholesterolemia, severe hypertriglyceridemia and pancreatitis", Journal of Young Pharmacists, 2013 Jun .
Gupta D, Shukla P, Bisht SS, Bhatt ML, Pant MC, Srivastava K, "Deep vein and artery thrombosis associated with cetuximab-based chemoradiotherapy", Indian journal of pharmacology, 2011 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on cetuximab (the active ingredients of Erbitux) and Erbitux (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.